1607962 - Rewalk Robotics Ltd. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Orthopedic, Prosthetic & Surgical Appliances & Supplies - RWLK (1607962)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
69 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S37-1-6-13-60

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-10-10
RWLKGricci JodiVP Global Marketing, TrainingS - Sale$1.50-6732,5900%-$101
D
2017-10-05
RWLKJasinski Lawrence JCEOA - Grant$0.00+78,285144,565+118%+$0
D
2017-10-05
RWLKKoren OfirSnr VP, R, D, RegulatoryA - Grant$0.00+13,40126,966+99%+$0
D
2017-10-05
RWLKGricci JodiVP Global Marketing, TrainingA - Grant$0.00+12,37632,657+61%+$0
D
2017-10-05
RWLKHershberger KevinCFOA - Grant$0.00+62,00695,676+184%+$0
2017-09-15
RWLKJasinski Lawrence JCEOF - Tax$1.80-61366,280-1%-$1,103
2017-08-28
RWLKJasinski Lawrence JCEOS - Sale$1.65-41366,893-1%-$681
2017-07-10
RWLKGricci JodiVP Global Marketing, TrainingS - Sale$1.45-11820,281-1%-$171
AD
2017-06-27
RWLKJasinski Lawrence JCEOA - Grant$0.00+25,00067,306+59%+$0
D
2017-06-27
RWLKJasinski Lawrence JCEOA - Grant$0.00+25,00067,306+59%+$0
M
2017-06-26
RWLKDykan JeffDir, 10%S - Sale$3.05-87,0001,506,122-5%-$265,652
M
2017-06-26
RWLKWeisman WayneDir, 10%S - Sale$3.05-87,0001,506,122-5%-$265,652
M
2017-06-26
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$3.05-21,782339,900-6%-$66,511
M
2017-06-26
RWLKScp Vitalife Partners II LP10%S - Sale$3.05-65,2181,017,674-6%-$199,141
2017-06-15
RWLKJasinski Lawrence JCEOF - Tax$1.15-61242,306-1%-$704
2017-05-30
RWLKJasinski Lawrence JCEOF - Tax$1.20-1,78242,918-4%-$2,138
2017-05-22
RWLKGricci JodiVP Global Marketing, TrainingS - Sale$1.15-26620,399-1%-$306
2017-05-22
RWLKHershberger KevinCFOS - Sale$1.15-98033,670-3%-$1,127
D
2017-04-18
RWLKGricci JodiVP Global Marketing, TrainingA - Grant$0.00+15,00020,665+265%+$0-5-15
D
2017-04-18
RWLKHershberger KevinCFOA - Grant$0.00+19,25034,650+125%+$0-5-15
D
2017-04-18
RWLKKoren OfirSnr VP, R, D, RegulatoryA - Grant$0.00+7,50013,565+124%+$0-5-15
DM
2017-01-03
RWLKKoren OfirSnr VP, R, D, RegulatoryM - OptEx$1.32+5,2206,065+618%+$6,8900-7-28
DM
2017-01-03
RWLKKoren OfirSnr VP, R, D, RegulatoryS - Sale+OE$3.45-5,2206,065-46%-$18,0200-7-28
2017-03-15
RWLKJasinski Lawrence JCEOF - Tax$1.95-62244,700-1%-$1,213+10+3
2016-12-15
RWLKJasinski Lawrence JCEOF - Tax$2.75-59645,322-1%-$1,639+9+4-4
2016-09-15
RWLKJasinski Lawrence JCEOF - Tax$5.74-59645,918-1%-$3,4210+3-3-66
2016-07-25
RWLKHamilton John VincentVP, Regulatory, ClinicalS - Sale$6.80-715,665-1%-$483+1-2-8-67
2016-07-25
RWLKGricci JodiVP Global Marketing, TrainingS - Sale$6.80-715,665-1%-$483+1-2-8-67
M
2016-08-15
RWLKDykan JeffDir, 10%S - Sale$6.37-100,0001,593,122-6%-$636,852+1-2-8-67
M
2016-08-15
RWLKWeisman WayneDir, 10%S - Sale$6.37-100,0001,593,122-6%-$636,852+1-2-8-67
M
2016-08-15
RWLKScp Vitalife Partners II LP10%S - Sale$6.37-74,9621,082,892-6%-$477,397+1-2-8-67
M
2016-08-15
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$6.37-25,038361,682-6%-$159,455+1-2-8-67
2016-06-15
RWLKJasinski Lawrence JCEOF - Tax$6.55-59646,514-1%-$3,904+4+6+15-49
M
2016-06-02
RWLKDykan JeffDir, 10%S - Sale$7.89-19,0601,693,122-1%-$150,431-3-14-19-63
M
2016-06-02
RWLKWeisman WayneDir, 10%S - Sale$7.89-19,0601,693,122-1%-$150,431-3-14-19-63
M
2016-06-02
RWLKScp Vitalife Partners II LP10%S - Sale$7.89-14,2881,157,854-1%-$112,768-3-14-19-63
M
2016-06-02
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.89-4,772386,720-1%-$37,663-3-14-19-63
M
2016-05-31
RWLKWeisman WayneDir, 10%S - Sale$7.74-11,3701,712,182-1%-$88,018+1-12-18-67
M
2016-05-31
RWLKDykan JeffDir, 10%S - Sale$7.74-11,3701,712,182-1%-$88,018+1-12-18-67
M
2016-05-31
RWLKScp Vitalife Partners II LP10%S - Sale$7.74-8,5231,172,142-1%-$65,979+1-12-18-67
M
2016-05-31
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.74-2,847391,492-1%-$22,039+1-12-18-67
M
2016-05-25
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$8.69-6,766394,339-2%-$58,808-4-3-25-64
M
2016-05-25
RWLKScp Vitalife Partners II LP10%S - Sale$8.69-20,2561,180,665-2%-$176,059-4-3-25-64
M
2016-05-25
RWLKWeisman WayneDir, 10%S - Sale$8.69-27,0221,723,552-2%-$234,866-4-3-25-64
M
2016-05-25
RWLKDykan JeffDir, 10%S - Sale$8.69-27,0221,723,552-2%-$234,866-4-3-25-64
D
2016-05-18
RWLKGricci JodiVP Global Marktng, TrainingA - Grant$0.00+3,3505,736+140%+$0-5-9-26-67
DM
2016-01-13
RWLKGricci JodiVP Global Marktng, TrainingS - Sale+OE$9.84-3295,736-5%-$3,237-5-9-26-67
D
2016-05-18
RWLKHamilton John VincentVP, Regulatory, ClinicalA - Grant$0.00+3,3505,736+140%+$0-5-9-26-67
DM
2016-01-13
RWLKHamilton John VincentVP, Regulatory, ClinicalS - Sale+OE$9.84-3295,736-5%-$3,237-5-9-26-67
D
2016-05-18
RWLKKoren OfirSnr VP, Research, DevelopmentA - Grant$0.00+3,3506,065+123%+$0-5-9-26-67
D
2016-05-24
RWLKJasinski Lawrence JCEOA - Grant$0.00+20,00047,110+74%+$0-5-9-26-67
D
2016-05-18
RWLKHershberger KevinCFOA - Grant$0.00+15,40015,400New+$0-5-9-26-67
M
2016-05-23
RWLKDykan JeffDir, 10%S - Sale$8.99-1,4001,750,5740%-$12,590-1-12-23-70
M
2016-05-23
RWLKWeisman WayneDir, 10%S - Sale$8.99-1,4001,750,5740%-$12,590-1-12-23-70
M
2016-05-23
RWLKScp Vitalife Partners II LP10%S - Sale$8.99-1,0501,200,9210%-$9,443-1-12-23-70
M
2016-05-23
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$8.99-350401,1050%-$3,148-1-12-23-70
M
2016-05-19
RWLKDykan JeffDir, 10%S - Sale$9.09-16,1481,751,974-1%-$146,805-3-8-23-69
M
2016-05-19
RWLKWeisman WayneDir, 10%S - Sale$9.09-16,1481,751,974-1%-$146,805-3-8-23-69
M
2016-05-19
RWLKScp Vitalife Partners II LP10%S - Sale$9.09-12,1051,201,971-1%-$110,050-3-8-23-69
M
2016-05-19
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$9.09-4,043401,455-1%-$36,756-3-8-23-69
2016-03-15
RWLKJasinski Lawrence JCEOF - Tax$8.56-61327,110-2%-$5,247-30+15-35
2016-03-07
RWLKDykan JeffDir, 10%S - Sale$8.33-3,0021,768,1220%-$25,007-1-6+4-36
2016-03-07
RWLKWeisman WayneDir, 10%S - Sale$8.33-3,0021,768,1220%-$25,007-1-6+4-36
M
2016-03-03
RWLKDykan JeffDir, 10%S - Sale$8.71-6,9991,771,1230%-$60,992-1+3+7-34
M
2016-03-03
RWLKWeisman WayneDir, 10%S - Sale$8.71-6,9991,771,1230%-$60,992-1+3+7-34
2016-01-15
RWLKScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$10.30-12,519405,498-3%-$128,906-1-3+5-40
2016-01-15
RWLKScp Vitalife Partners II LP10%S - Sale$10.30-37,4811,214,076-3%-$385,934+8+4+12-32
2016-01-15
RWLKWeisman WayneDir, 10%S - Sale$10.30-50,0001,778,122-3%-$514,840+8+4+12-32
2016-01-15
RWLKDykan JeffDir, 10%S - Sale$10.30-50,0001,778,122-3%-$514,840+8+4+12-32

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top